Minturn JE, Fryer HJ, Geschwind DH and Hockfield S: TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth. J Neurosci. 15:6757–6766. 1995.PubMed/NCBI

Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M and Nonaka M: A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene. 180:157–163. 1996. View Article : Google Scholar

Byk T, Dobransky T, Cifuentes-Diaz C and Sobel A: Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product. J Neurosci. 16:688–701. 1996.

Quinn CC, Gray GE and Hockfield S: A family of proteins implicated in axon guidance and outgrowth. J Neurobiol. 41:158–164. 1999. View Article : Google Scholar : PubMed/NCBI

Byk T, Ozon S and Sobel A: The Ulip family phosphoproteins-common and specific properties. Eur J Biochem. 254:14–24. 1998. View Article : Google Scholar : PubMed/NCBI

Horiuchi M, El Far O and Betz H: Ulip6, a novel unc-33 and dihydropyrimidinase related protein highly expressed in developing rat brain. FEBS Lett. 480:283–286. 2000. View Article : Google Scholar : PubMed/NCBI

Fukada M, Watakabe I, Yuasa-Kawada J, et al: Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J Biol Chem. 275:37957–37965. 2000. View Article : Google Scholar

Inatome R, Tsujimura T, Hitomi T, et al: Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. J Biol Chem. 275:27291–27302. 2000.

Li W, Herman RK and Shaw JE: Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33. Genetics. 132:675–689. 1992.

Quach TT, Duchemin AM, Rogemond V, et al: Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons. Mol Cell Neurosci. 25:433–443. 2004. View Article : Google Scholar : PubMed/NCBI

Uchida Y, Ohshima T, Sasaki Y, et al: Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer’s disease. Genes Cells. 10:165–179. 2005.PubMed/NCBI

Fukata Y, Itoh TJ, Kimura T, et al: CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol. 4:583–591. 2002.PubMed/NCBI

Cole AR, Causeret F, Yadirgi G, et al: Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J Biol Chem. 281:16591–16598. 2006. View Article : Google Scholar

Hotta A, Inatome R, Yuasa-Kawada J, Qin Q, Yamamura H and Yanagi S: Critical role of collapsin response mediator protein-associated molecule CRAM for filopodia and growth cone development in neurons. Mol Biol Cell. 16:32–39. 2005. View Article : Google Scholar : PubMed/NCBI

Goshima Y, Nakamura F, Strittmatter P and Strittmatter SM: Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature. 376:509–514. 1995. View Article : Google Scholar : PubMed/NCBI

Uchida Y and Goshima Y: Molecular mechanism of axon guidance mediated by phosphorylation of CRMP2. Seikagaku. 77:1424–1427. 2005.(In Japanese).

Yoshimura T, Kawano Y, Arimura N, Kawabata S and Kaibuchi K: Molecular mechanisms of neuronal polarity. Nihon Shinkei Seishinhin Yakurigaku Zasshi. 25:169–174. 2005.(In Japanese).

Lin PC, Chan PM, Hall C and Manser E: Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction. J Biol Chem. 286:41466–41478. 2011. View Article : Google Scholar

Yoshimura T, Arimura N, Kawano Y, Kawabata S, Wang S and Kaibuchi K: Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/CRMP-2 pathway. Biochem Biophys Res Commun. 340:62–68. 2006. View Article : Google Scholar : PubMed/NCBI

Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A and Kaibuchi K: GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell. 120:137–149. 2005. View Article : Google Scholar : PubMed/NCBI

Lykissas MG, Batistatou AK, Charalabopoulos KA and Beris AE: The role of neurotrophins in axonal growth, guidance, and regeneration. Curr Neurovasc Res. 4:143–151. 2007. View Article : Google Scholar : PubMed/NCBI

Moolenaar WH: Development of our current understanding of bioactive lysophospholipids. Ann N Y Acad Sci. 905:1–10. 2000. View Article : Google Scholar

Chun J, Weiner JA, Fukushima N, et al: Neurobiology of receptor-mediated lysophospholipid signaling. From the first lysophospholipid receptor to roles in nervous system function and development. Ann N Y Acad Sci. 905:110–117. 2000. View Article : Google Scholar

Arimura N, Inagaki N, Chihara K, et al: Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem. 275:23973–23980. 2000. View Article : Google Scholar

Patrakitkomjorn S, Kobayashi D, Morikawa T, et al: Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2. J Biol Chem. 283:9399–9413. 2008. View Article : Google Scholar

Shih JY, Yang SC, Hong TM, et al: Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst. 93:1392–1400. 2001. View Article : Google Scholar : PubMed/NCBI

Chen JJ, Peck K, Hong TM, et al: Global analysis of gene expression in invasion by a lung cancer model. Cancer Res. 61:5223–5230. 2001.PubMed/NCBI

Shih JY, Lee YC, Yang SC, Hong TM, Huang CY and Yang PC: Collapsin response mediator protein-1: a novel invasion-suppressor gene. Clin Exp Metastasis. 20:69–76. 2003. View Article : Google Scholar : PubMed/NCBI

Wu CC, Lin JC, Yang SC, et al: Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPalpha. Mol Cancer Ther. 7:1365–1375. 2008. View Article : Google Scholar : PubMed/NCBI

Khuri FR, Wu H, Lee JJ, et al: Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res. 7:861–867. 2001.PubMed/NCBI

Riedl K, Krysan K, Põld M, et al: Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat. 7:169–184. 2004. View Article : Google Scholar : PubMed/NCBI

Masferrer JL, Leahy KM, Koki AT, et al: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60:1306–1311. 2000.PubMed/NCBI

Grösch S, Tegeder I, Niederberger E, Bräutigam L and Geisslinger G: COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J. 15:2742–2744. 2001.

Yao M, Lam EC, Kelly CR, Zhou W and Wolfe MM: Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. Br J Cancer. 90:712–719. 2004. View Article : Google Scholar : PubMed/NCBI

Xie D, Nakachi K, Wang H, Elashoff R and Koeffler HP: Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61:8917–8923. 2001.

Wenger C, Ellenrieder V, Alber B, Lacher U, et al: Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene. 18:1073–1080. 1999. View Article : Google Scholar : PubMed/NCBI

Kubo M, Kikuchi K, Nashiro K, et al: Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol. 139:192–197. 1998. View Article : Google Scholar : PubMed/NCBI

Shakunaga T, Ozaki T, Ohara N, et al: Expression of connective tissue growth factor in cartilaginous tumors. Cancer. 89:1466–1473. 2000. View Article : Google Scholar : PubMed/NCBI

Chang CC, Shih JY, Jeng YM, et al: Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Natl Cancer Inst. 96:364–375. 2004. View Article : Google Scholar : PubMed/NCBI

Pan SH, Chao YC, Hung PF, et al: The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. J Clin Invest. 121:3189–3205. 2011. View Article : Google Scholar : PubMed/NCBI

Pan SH, Chao YC, Chen HY, et al: Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. Lung Cancer. 67:93–100. 2010. View Article : Google Scholar

Wang WL, Hong TM, Chang YL, Wu CT, Pan SH and Yang PC: Phosphorylation of LCRMP-1 by GSK3beta promotes filopodia formation, migration and invasion abilities in lung cancer cells. PLoS One. 7:e316892012. View Article : Google Scholar : PubMed/NCBI

Wu CC, Chen HC, Chen SJ, et al: Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics. 8:316–332. 2008. View Article : Google Scholar

Oliemuller E, Peláez R, Garasa S, et al: Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC. Int J Cancer. 132:1986–1995. 2013. View Article : Google Scholar

Shimada K, Ishikawa T, Nakamura F, et al: Collapsin response mediator protein 2 is involved in regulating breast cancer progression. Breast Cancer. Feb 5–2013.(Epub ahead of print).

Goodyear S and Sharma MC: Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Exp Mol Pathol. 82:25–32. 2007. View Article : Google Scholar

Upadhyay AK, Ajay AK, Singh S and Bhat MK: Cell cycle regulatory protein 5 (Cdk5) is a novel downstream target of ERK in carboplatin induced death of breast cancer cells. Curr Cancer Drug Targets. 8:741–752. 2008. View Article : Google Scholar

Prasad CP, Rath G, Mathur S, Bhatnagar D, Parshad R and Ralhan R: Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer. 9:3252009. View Article : Google Scholar : PubMed/NCBI

Gao X, Pang J, Li LY, et al: Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene. 29:4555–4566. 2010. View Article : Google Scholar : PubMed/NCBI

Rosslenbroich V, Dai L, Baader SL, Noegel AA, Gieselmann V and Kappler J: Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res. 310:434–444. 2005. View Article : Google Scholar : PubMed/NCBI

Hiroshima Y, Nakamura F, Miyamoto H, et al: Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer. Ann Surg Oncol. 20(Suppl 3): S369–S378. 2013. View Article : Google Scholar

Gaetano C, Matsuo T and Thiele CJ: Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells. J Biol Chem. 272:12195–12201. 1997. View Article : Google Scholar : PubMed/NCBI

Choi YL, Kim CJ, Matsuo T, et al: HUlip, a human homologue of unc-33-like phosphoprotein of Caenorhabditis elegans; Immunohistochemical localization in the developing human brain and patterns of expression in nervous system tumors. J Neurooncol. 73:19–27. 2005.PubMed/NCBI

Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ and Li Z: Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci. 104:1586–1592. 2013. View Article : Google Scholar : PubMed/NCBI

Quinn CC, Chen E, Kinjo TG, et al: TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone. J Neurosci. 23:2815–2823. 2003.PubMed/NCBI

Yuasa-Kawada J, Suzuki R, Kano F, Ohkawara T, Murata M and Noda M: Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur J Neurosci. 17:2329–2343. 2003. View Article : Google Scholar : PubMed/NCBI

Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE and Lennon VA: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 49:146–154. 2001. View Article : Google Scholar : PubMed/NCBI

Monstad SE, Drivsholm L, Skeie GO, Aarseth JH and Vedeler CA: CRMP5 antibodies in patients with small-cell lung cancer or thymoma. Cancer Immunol Immunother. 57:227–232. 2008. View Article : Google Scholar : PubMed/NCBI

Asamura H, Kameya T, Matsuno Y, et al: Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol. 24:70–76. 2006. View Article : Google Scholar : PubMed/NCBI

Meyronet D, Massoma P, Thivolet F, et al: Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. Am J Surg Pathol. 32:1699–1708. 2008. View Article : Google Scholar : PubMed/NCBI

Lacroix M, Abi-Said D, Fourney DR, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 95:190–198. 2001. View Article : Google Scholar

Liang Y, Diehn M, Watson N, et al: Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA. 102:5814–5819. 2005. View Article : Google Scholar : PubMed/NCBI

Brot S, Rogemond V, Perrot V, et al: CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2. J Neurosci. 30:10639–10654. 2010. View Article : Google Scholar : PubMed/NCBI